---
title: "Huaxia Eye: The overall operation of the new refractive surgical technique is good"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224983117.md"
description: "Huaxia Eye (301267) stated in an institutional research on January 14 that since the beginning of last year, the company has introduced two new refractive surgical techniques: Alcon's full optical plastic and the femtosecond precision 4.0. The operational situation is good. The femtosecond 4.0 technique has shown outstanding performance in increasing the average transaction value and the number of surgeries. The company plans to gradually promote new equipment and technologies in more hospitals according to market demand to meet patients' personalized diagnosis and treatment needs"
datetime: "2025-01-15T02:58:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224983117.md)
  - [en](https://longbridge.com/en/news/224983117.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224983117.md)
generator: "portal-rs"
---

# Huaxia Eye: The overall operation of the new refractive surgical technique is good

On January 14th, Huaxia Eye stated during an institutional research that since the beginning of last year, the company has successively introduced two new refractive surgical techniques: Alcon's full optical plastic and the all-laser femtosecond precision 4.0. From the hospitals that have already launched these services, the overall operational situation is good. In particular, the all-laser femtosecond 4.0, although it entered the market later, the hospitals under the company are still gradually updating their equipment. However, from the hospitals that have already started promoting the business, this technique has been able to play a significant role in enhancing both the average transaction value and the number of surgeries. In the future, the company will gradually introduce and promote new ophthalmic diagnostic and treatment equipment and technologies in more of its affiliated hospitals based on market demand and operational conditions, to meet the multi-level and personalized diagnostic and treatment service needs of patients

### Related Stocks

- [301267.CN](https://longbridge.com/en/quote/301267.CN.md)
- [300015.CN](https://longbridge.com/en/quote/300015.CN.md)
- [ALC.US](https://longbridge.com/en/quote/ALC.US.md)
- [002524.CN](https://longbridge.com/en/quote/002524.CN.md)
- [301239.CN](https://longbridge.com/en/quote/301239.CN.md)
- [02219.HK](https://longbridge.com/en/quote/02219.HK.md)

## Related News & Research

- [Dino Polska S.A. (WSE:DNP) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296763667.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Atomic Eagle Re-Establishes 60% Operating Interest in Madaouela Uranium Project](https://longbridge.com/en/news/296731180.md)
- [Msheireb Properties partners with Inc. Arabia to host business innovation events in Doha](https://longbridge.com/en/news/296761630.md)
- [Predict signs Italy healthcare distribution deal for Robocore’s “temi” service robots](https://longbridge.com/en/news/296769892.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**